Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2021, Vol. 07 ›› Issue (01): 76-80. doi: 10.3877/cma.j.issn.2096-1537.2021.01.013

Special Issue:

• Treatment Experiences • Previous Articles     Next Articles

Efficacy and safety analysis of Ceftazidime-Avibatam in carbapene-resistant Klebsiella pneumoniae infected patients with septic shock

He Sun1, Chunfeng He1, Xiaodong Wu1, Huize Han1, Yi Shi2, Qiang Li1,()   

  1. 1. Department of Respiratory and Critical Care Medicine, East Hospital of Tongji University, Shanghai 200120, China
    2. Department of Respiratory and Critical Care Medicine, Nanjing Jinling Hospital, Nanjing University, School of Medicine, Nanjing 210002, China
  • Received:2020-07-04 Online:2021-02-28 Published:2021-04-23
  • Contact: Qiang Li

Abstract:

Objective

To investigate efficacy and safety of Ceftazidime-Avibactam (CZA) in the treatment of septic shock patients infected by carbapenem-resistant Klebsiella pneumoniae (CRKP).

Methods

Clinical data of 4 patients with septic shock caused by CRKP infection who were treated with CZA was retrospectively analyzed. Sequential organ failure assessment (SOFA) score before and after CZA treatment was collected for clinical efficacy and side effect assessment.

Results

Among these 4 patients, 2 were female and 2 were male, aged 72-79 years. Klebsiella pneumoniae was cultured from alveolar lavage fluid, drainaged bile or blood samples, respectively. All cultures of Klebsiella pneumoniae were carbapenem-resistent but sensitive to CZA. After CZA prescription, SOFA score, clinical manifestations and inflammatory biomarkers of these patients were significantly improved and they all discharged home. No side effects related to CZA were reported.

Conclusion

CZA is effective and safe for septic shock patients infected by carbapenem resistant Klebsiella pneumoniae.

Key words: Carbapenem-resistant Klebsiella pneumoniae, Septic shock, Ceftazidime-Avibatan

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd